Cargando…
Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death
Induction of tumor cell death is the therapeutic goal for most anticancer drugs. Yet, a mode of drug-induced cell death, known as immunogenic cell death (ICD), can propagate antitumoral immunity to augment therapeutic efficacy. Currently, the molecular hallmark of ICD features the release of damage-...
Autores principales: | Hayashi, K., Nikolos, F., Lee, Y. C., Jain, A., Tsouko, E., Gao, H., Kasabyan, A., Leung, H. E., Osipov, A., Jung, S. Y., Kurtova, A. V., Chan, K. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721802/ https://www.ncbi.nlm.nih.gov/pubmed/33288764 http://dx.doi.org/10.1038/s41467-020-19970-9 |
Ejemplares similares
-
Inhibitory DAMPs in immunogenic cell death and its clinical implications
por: Hayashi, Kazukuni, et al.
Publicado: (2021) -
Co‐Anchoring of Engineered Immunogen and Immunostimulatory Cytokines to Alum Promotes Enhanced‐Humoral Immunity
por: Chang, Jason Y. H., et al.
Publicado: (2022) -
Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors
por: Nikolos, Fotis, et al.
Publicado: (2022) -
Enhancing the immunogenicity of cancer vaccines by harnessing CLEC9A
por: Lahoud, M. H., et al.
Publicado: (2021) -
Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice
por: Zhang, Jinguo, et al.
Publicado: (2022)